High concentrations of human β-defensin 2 in gastric juice of patients with Helicobacter pylori infection

World Journal of Gastroenterology

Volumn 11, Issue 31, 2005, Pages 4782-4787

  Isomoto, Hajime ^a   Mukae, Hiroshi ^a   Ishimoto, Hiroshi ^a   Nishi, Yoshito ^a   Wen, Chun Yang ^a   Wada, Akihiro ^a   Ohnita, Ken ^a   Hirayama, Toshiya ^a   Nakazato, Masamitsu ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Helicobacter pylori; defensin 1; defensin 2

Indexed keywords

AMOXICILLIN; BETA DEFENSIN 1; BETA DEFENSIN 2; CLARITHROMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LANSOPRAZOLE;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH JUICE; STOMACH MUCOSA;

EID: 24044505975     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i31.4782     Document Type: Article

References (33)

1. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626-633
2. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Ann Rev Microbiol 2000; 54: 615-640
3. Zevering Y, Jacob L, Meyer TF. Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut 1999; 45: 465-474
4. Shimoyama T, Crabtree JE. Bacterial factors and immune pathogenesis in Helicobacter pylori infection. Gut 1998; 43 (Suppl 1): S2-S5
5. Allen LA. The role of the neutrophils and phagocytosis in infection caused by Helicobacter pylori. Curr Opin Infect Dis 2001; 14: 273-277
6. Isomoto H, Inoue K, Furusu H, Enjoji A, Fujimoto C, Yamakawa M, Hirakata Y, Omagari K, Mizuta Y, Murase K, Shimada S, Murata I, Kohno S. High-dose rabeprazole/amoxicillin vs rabeprazole/amoxicillin/metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection. Aliment Pharmacol Ther 2003; 18: 101-107
7. van Wetering S, Sterk PJ, Rabe KF, Hiemstra PS. Defensins: Key players or bystanders in infection, injury, and repair in the lung. J Allergy Clin Immunol 1999; 104: 1131-1138
8. Chertov O, Yang D, Howard OMZ, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000; 177: 68-78
9. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000; 1: 141-150
10. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707-5713
11. Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R, Forssmann WG. Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001; 15: 1819-1821
12. O'Neil DA, Cole SP, Martin-Porter E, Housley MP, Liu L, Ganz T, Kagnoff MF. Regulation of human β-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect Immun 2000; 68: 5412-5415
13. Bajaj-Elliott M, Smith GV, Domizio P, Maher L, Ali RS, Quinn AG, Farthing MJG. Modulation of host antimicrobial peptide (β-defensins 1 and 2) expression during gastritis. Gut 2002; 51: 356-361
14. Uehara N, Yagihashi A, Kondoh K, Tsuji N, Fujita T, Hamada H, Watanabe N. Human β-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: antimicrobial effect of overexpression. J Med Microbiol 2003; 52: 41-45
15. Hamanaka Y, Nakashima M, Wada A, Ito M, Kurazono H, Hoji H, Nakahara Y, Kohno S, Hirayama T, Sekine I. Expression of human β-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut 2001; 49: 481-487
16. Wehkamp J, Schmidt K, Herrlinger KR, Baxmann S, Behling S, Wohlschlager C, Feller AC, Stange EF, Fellermann K. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol 2003; 56: 352-357
17. Hiratsuka T, Nakazato M, Date Y, Ashitani JI, Minematsu T, Chino N, Matsukura S. Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 1998; 249: 943-947
18. 2-receptor antagonist, versus lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori. Helicobacter 2003; 8: 111-119
19. Price AB. The Sydney system; histological division. J Gastroenterol Hepatol 1991; 6: 209-222
20. Isomoto H, Miyazaki M, Mizuta Y, Takeshima F, Murase K, Inoue K, Yamasaki K, Murata I, Koji T, Kohno S. Expression of nuclear factor kB in Helicobacter pylori-infected gastric mucosa detected with Southwestern histochemistry. Scand J Gastroenterol 2000; 35: 247-254
21. Morini S, Zullo A, Hassan C, Lorenzetti R, Stella F, Martini MT. Gastric cardiac inflammation: Role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 2337-2340
22. Isomoto H, Mizuta Y, Miyazaki M, Takeshima F, Omagari K, Murase K, Nishiyama T, Inoue K, Murata I, Kohno S. Implication of NF-kB in Helicobacter pylori-associated gastritis. Am J Gastroenterol 2000; 95: 2768-2776
23. Isomoto H, Furusu H, Morikawa T, Mizuta Y, Nishiyama T, Omagari K, Murase K, Inoue K, Murata I, Kohno S. 5-d vs 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14: 1619-1623
24. Isomoto H, Wang A, Mizuta Y, Akazawa Y, Ohba K, Omagari K, Miyazaki M, Murase K, Hayashi T, Inoue K, Murata I, Kohno S. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 2003; 98: 551-556
25. Hiratsuka T, Mukae H, Iiboshi H, Ashitani J, Nabeshima K, Minematsu T, Chino N, Ihi T, Kohno S, Nakazato M. Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Thorax 2003; 58: 425-430.
26. George JT, Boughan PK, Karageorgiou H, Bajaj-Elliott M. Host anti-microbial response to Helicobacter pylori infection. Mol Immunol 2003; 40: 451-456
27. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-1447
28. Fallone CA, Barkun AN, Friedman G, Mayrand S, Loo V, Beech R, Best L, Joseph L. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 2000; 95: 914-920
29. Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, Shimosegawa T, Toyota T. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000; 46: 20-26
30. Raj PA, Dentino AR. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett 2002; 206: 9-18
31. Barnes PJ, Karin M. Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071
32. Wada A, Ogushi K, Kimura T, Hojo H, Mori N, Suzuki S, Kumatori A, Se M, Nakahara Y, Nakamura M, Moss J, Hirayama T. Helicobacter pylori-mediated transcriptional regulation of the human β-defensin 2 gene requires NFκB. Cell Microbiol 2001; 3: 114-123
33. Zhao C, Wang I, Lehrer RI. Widespread expression of β-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396: 319-322